CSF3 and neoplasm: These data are consistent with the undetectable levels of tumor-derived G-CSF and low MDSC burden in the parental CMS4 model, and reinforces the likelihood that anti-Gr-1 mAb treatment did not exert non-specific effects against tumor growth.